Novartis Fortifies RLT Pipeline with Mariana Oncology Acquisition

Transaction reinforces company’s strategic focus on developing next-generation treatment options for patients living with cancer Mariana Oncology ...

May 03, 2024 | Friday | News
Thermo Fisher Scientific Welcomes Historic Czech Delegation, Strengthening International Ties in Science and Trade

Thermo Fisher Scientific, the world leader in serving science, was proud to welcome Jozef Sikela, Minister of Industry and Trade of the Czech Republic, alo...

May 03, 2024 | Friday | News
ARS Pharmaceuticals Advances neffy® MAA with CHMP Response, Inks CSL Seqirus Deal for Australia & New Zealand

CHMP opinion on neffy Marketing Authorization Application anticipated in the second quarter of 2024 Response addresses all issues previously identified by...

May 01, 2024 | Wednesday | News
Johnson & Johnson Unifies Business Segments, Enhancing Healthcare Solutions in the UK

Johnson & Johnson announced it is updating its brand and uniting both its two business segments under the Johnson & Johnson brand name in the UK. ...

May 01, 2024 | Wednesday | News
QIAGEN's Quantum Leap: CEO Thierry Bernard Heralds First Quarter Triumph with Stellar Growth in Key Areas!

Q1 2024: Net sales of $459 million (-5% actual rates, -5% constant exchange rates, CER); diluted EPS of $0.36 and adjusted diluted EPS of $0.46 Net ...

April 30, 2024 | Tuesday | Company results
Gilead's CEO Daniel O'Day Projects Robust Growth in 2024 Amidst Promising Acquisition and Pipeline Advancements

Gilead Sciences Announces First Quarter 2024 Financial Results Product Sales Excluding Veklury Increased 6% Year-Over-Year to $6.1 billion Biktarvy...

April 26, 2024 | Friday | Company results
German Chancellor Olaf Scholz Lauds Merck's €300 Million Investment in New Darmstadt Research Center, Bolstering Germany as a Top Biopharmaceutical Hub

German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony Research center to accelerate biop...

April 26, 2024 | Friday | News
Gain Therapeutics Reports Positive Results from Phase 1 Study of GT-02287, Showcasing Promising Safety and Tolerability Profile

Gain Therapeutics, a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapi...

April 25, 2024 | Thursday | News
QIAGEN Launches Breakthrough NGS Panel to Bolster Tuberculosis Surveillance and Combat Antimicrobial Resistance

    QIAGEN  announced the launch of the QIAseq xHYB Mycobacterium tuberculosis Panel for research use, a new tool in the fight against t...

April 25, 2024 | Thursday | News
Exergen Corporation Takes Legal Action to Protect Rights in Face of Baxter International's Censorship Attempt

Exergen Corporation, a leader in temperature measurement technology, has filed a lawsuit against Baxter International Inc. in the United States District Co...

April 24, 2024 | Wednesday | News
ChargePoint Technology Invests in New Manufacturing Facility to Meet Growing Demand for Single-Use Solutions

  ChargePoint Technology, a specialist in powder and liquid transfer, has invested in a new manufacturing facility dedicated to its single-u...

April 24, 2024 | Wednesday | News
Bruker Corporation to Acquire NanoString Technologies for $392.6 Million, Ensuring Continuity of Leading Life Science Tools

NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translati...

April 18, 2024 | Thursday | News
Beckman Coulter Life Sciences Stuns at INTERPHEX 2024 with Game-Changing QbD1200+ TOC Analyzer

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, makes pharmaceutical and biopharmaceutical analysis faster and simp...

April 16, 2024 | Tuesday | News
Agilent Technologies' GenetiSure Dx Postnatal Assay Earns European IVDR Class C Certification

Agilent Technologies Inc.  announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demon...

April 15, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close